Weight regain after discontinuation: difference between revisions
Diff·revision 12 → 13·08:18, 22 Feb 2025
Difference between revision 12 and revision 13 of Weight regain after discontinuation. 3 lines changed; the page grew by 335 bytes.
| Revision 12 — 04:40, 5 Feb 2025 NauseaNoor (talk) add the note that titration exists partly to manage these effects 3,696 bytes +126 | Revision 13 — 08:18, 22 Feb 2025 ArchiveBot (talk) bot: add maintenance category 4,031 bytes +335 | ||
|---|---|---|---|
| 27 | It is also not unique to this class. Weight regain follows cessation of essentially every weight-management intervention that is stopped, including diet and structured lifestyle programmes, and the pattern here resembles that literature rather than departing from it.{{r|wilding2021}} | 27 | It is also not unique to this class. Weight regain follows cessation of essentially every weight-management intervention that is stopped, including diet and structured lifestyle programmes, and the pattern here resembles that literature rather than departing from it.{{r|wilding2021}} |
| 28 | 28 | ||
| + | 29 | What the trials do establish is that any decision about duration must be made in the knowledge that the effect is contingent on continued exposure. This wiki gives no advice on such decisions.{{r|ada2024}} | |
| + | 30 | ||
| 29 | == References == | 31 | == References == |
| 30 | {{reflist}} | 32 | {{reflist}} |
| ⋮ | ⋮ | ||
| 32 | <ref name="drucker2018">Drucker DJ. "Mechanisms of action and therapeutic application of glucagon-like peptide-1." ''Cell Metabolism'' 27(4):740–756 (2018). PMID 29617641.</ref> | 34 | <ref name="drucker2018">Drucker DJ. "Mechanisms of action and therapeutic application of glucagon-like peptide-1." ''Cell Metabolism'' 27(4):740–756 (2018). PMID 29617641.</ref> |
| 33 | <ref name="wilding2021">Wilding JPH, Batterham RL, Calanna S, et al. "Once-weekly semaglutide in adults with overweight or obesity." ''New England Journal of Medicine'' 384(11):989–1002 (2021). PMID 33567185.</ref> | 35 | <ref name="wilding2021">Wilding JPH, Batterham RL, Calanna S, et al. "Once-weekly semaglutide in adults with overweight or obesity." ''New England Journal of Medicine'' 384(11):989–1002 (2021). PMID 33567185.</ref> |
| + | 36 | <ref name="ada2024">American Diabetes Association. "Standards of Care in Diabetes." ''Diabetes Care'' 47(Suppl 1) (2024).</ref> | |
| 34 | 37 | ||
| 35 | == See also == | 38 | == See also == |